|
1) Skinningsrud A, Stenset V, Gundersen AS, et al. Cerebrospinal fluid markers in Creutzfeldt-Jakob disease. Cerebrospinal Fluid Res. 2008; 5: 14
|
|
|
|
2) Bahl JM, Heegaard NH, Falkenhorst G, et al. The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimerʼs disease. Neurobiol Aging. 2009; 30: 1834-41
|
|
|
|
|
3) Gmitterova K, Heinemann U, Bodemer M, et al. 14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes. Neurobiol Aging. 2009; 30: 1842-50
|
|
|
|
|
|
4) Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009; 132: 2659-68
|
|
|
|
|
|
5) Satoh K, Shirabe S, Tsujino A, et al. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord. 2007; 24: 207-12
|
|
|
|
|
|
6) Castilla J, Saa P, Morales R, et al. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol. 2006; 412: 3-21
|
|
|
|
|
|
7) Atarashi R, Moore RA, Sim VL, et al. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat. Methods. 2007; 4: 645-50
|
|
|
|
|
|
8) Atarashi R, Wilham JM, Christensen L, et al. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat. Methods. 2008; 5: 211-2
|
|
|
|
|
|
9) Colby DW, Zhang Q, Wang S, et al. Prion detection by an amyloid seeding assay. Proc Natl Acad Sci U S A. 2007; 104: 20914-9
|
|
|
|
|
|
10) Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999; 46: 224-33
|
|
|
|
|
|
11) Hsich G, Kenney K, Gibbs CJ, et al. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med. 1996; 335: 924-30
|
|
|
|
|
|
12) Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol. 1998; 43: 32-40
|
|
|
|
|
|
13) Brandel JP, Delasnerie-Laupretre N, Laplanche JL, et al. Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Neurology. 2000; 54: 1095-9
|
|
|
|
|
|
14) Sanchez-Juan P, Green A, Ladogana A, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology. 2006; 67: 637-43
|
|
|
|
|
|
15) 袖山信幸. プリオン病及び遅発性ウイルス感染に関する調査研究 平成15年度研究報告書. 2004. p.59-64
|
|
|
|
|
|
16) Otto M, Wiltfang J, Cepek L, et al. Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology. 2002; 58: 192-7
|
|
|
|
|
|
17) Van Everbroeck B, Quoilin S, Boons J, et al. A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 2003; 74: 1210-4
|
|
|
|
|
|
18) Sanchez-Juan P, Sanchez-Valle R, Green A, et al. Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J Neurol. 2007; 254: 901-6
|
|
|
|
|
|
19) Huang N, Marie SK, Livramento JA, et al. 14-3-3 protein in the CSF of patients with rapidly progressive dementia. Neurology. 2003; 61: 354-7
|
|
|
|
|